← Back
$HIMS All transactions

Hims & Hers Health, Inc.

▼ SELL 10b5-1 Plan

$ Value

$758K

Shares

13,786

Price

$55

Filed

May 13

Insider

Name

Baird Melissa

Title

Chief Operating Officer

CIK

0001837815

Roles

Officer

Transaction Details

Transaction Date

2025-05-12

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

824,630

Footnotes

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.405 - $55.395. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.405 - $56.315. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.425 - $57.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.45 - $58.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. | Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.

Filing Info

Accession No.

0001773751-25-000162

Form Type

4

Issuer CIK

0001773751

Baird Melissa's History

Date Ticker Type Value
2025-05-12 HIMS M $81K
2025-05-12 HIMS $758K
2025-05-12 HIMS $380K
2025-05-12 HIMS $429K
2025-05-12 HIMS $300K
2025-05-12 HIMS M $0

Other Insiders at HIMS (90d)

Insider Bought Sold Last
Dudum Andrew
Chief Executive Officer
2026-04-09
Boughton Soleil
Chief Legal Officer
$473K 2026-04-20
Carroll Patrick Harrison
Chief Medical Officer
2026-03-13
Autor Deborah M.
Chief Policy Officer
2026-03-13
Becklund Irene
PAO
$137K 2026-03-17
Okupe Oluyemi
Chief Financial Officer
$2.5M 2026-04-20
Chi Michael
Chief Operating Officer
$2.4M 2026-03-17
Pendarvis Christiane 2026-03-13
Elshenawy Mohamed
CTO
2026-03-11